Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.

Pharmaceuticals

Oct 14, 2019, 05.16 PM IST
11,341.1536.1
Stock Analysis, IPO, Mutual Funds, Bonds & More
Sun Pharma launches Cequa to treat dry eye disease in US

One of the company's wholly-owned subsidiaries has commercialised Cequa 0.09 per cent in the US, Sun Pharma said in a filing to BSE.

Drug regulator steps up monitoring of ranitidine

The US FDA announced an update of testing of NDMA in ranitidine, warning manufacturers not to use a high-temperature test for NDMA as it generates high levels of the impurity.

Torrent Pharma recalls 74k bottles of hypertension drug from US

As per the report, Torrent Pharma Inc is recalling 17,088 bottles of Losartan Potassium /Hydrochlorothiazide tablets, USP 50mg/12.5mg from the same markets.

‘Karma’ catches up with Ranbaxy's Malvinder and Shivinder Singh

As India cleans up one of the world’s worst bad-loan mess, govt is cracking down on defaulting borrowers.

Daiichi-Ranbaxy case: Radha Soami chief claims in HC don't owe money to Singh brothers

Dhillons told the court that RHC Holding has made false claims that they owe money to the company.

Documents potentially misleading in Aurobindo Pharma's Unit-VII: USFDA

The FDA conducted a cGMP (Current Good Manufacturing Practices) inspection at the Unit 7 manufacturing facility from September 19-27 this year.

Patients' group opposes stent categorisation

In April 2015 and January 2018, expert committees examining the request for separate categories for 'innovative' stents had decided that there was no case for sub-categorisation due to the lack of clinical evidence of superiority of the 'innovative' stents over other drug eluting stents.

Chinese growth shot’s some years away for pharma companies

For most Indian pharmaceutical cos venturing into China, market is still restricted to licensing of speciality products & monetisation may take time.

India mulls radical change for faster vaccine availability

Halving time for approval, sidestepping animal testing of vaccines is on the cards.

Daiichi-Ranbaxy case: HC asks Radha Soami head, 54 others to deposit Rs 6,000 crore

Money will also be recovered from former Religare Enterprises chief Sunil Godhwani and his brother Sanjay Godhwani.

Regulator may go over the counter to tackle issue of drug overdose

Regulator may go over the counter to tackle issue of drug overdose

As per the Nicholas Hall 2017 report, the Indian OTC market is expected to grow at a compounded annual growth rate (CAGR) of 9% to cross the $6.5 billion mark by 2026.

Johnson Controls-Hitachi sets up global development center in Gujarat

Johnson Controls-Hitachi sets up global development center in Gujarat

The company has employed 150 engineers at this center for carrying out research and development, said Johnson Controls-Hitachi Air Conditioning CEO Franz Cerwinka.

USFDA red flags Lupin for significant violations at MP unit

USFDA red flags Lupin for significant violations at MP unit

The USFDA said it had inspected the Unit 1 at the Mandideep facility of the company from November 26 to December 4, 2018.

Lupin appoints Johnny Mikell as Global Head of Quality

Lupin appoints Johnny Mikell as Global Head of Quality

He will be based out of the company's US offices and will lead the quality function globally and, will help steer the company towards enhanced standards of quality and compliance, Lupin said

Shield Healthcare acquires two entities for undisclosed sum

Shield Healthcare acquires two entities for undisclosed sum

Following the acquisitions, Shield Healthcare aims to increase its presence in gynaecology and paediatrics, a company release said here on Thursday.

Lupin appoints Sreeji Gopinathan as its CIO

Lupin appoints Sreeji Gopinathan as its CIO

"Sreeji brings to Lupin over 20 years of significant domain expertise and global experience," Lupin said in a statement.

Load More...
1

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

BACK TO TOP